Supreme Court’s Copaxone Ruling Could Increase Expert Witness Testimony

High court rules Federal Circuit should have granted deference to district court’s decision on meaning of Copaxone patent claim; Federal Circuit must now reconsider its finding that the patent is invalid.

More from Legal & IP

More from Pink Sheet